Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Sotera Health Company (SHC)

18.02 -0.68 (-3.64%)
As of 12:12:27 PM EDT. Market Open.
Trade SHC on Coinbase
Chart Range Bar
Loading chart for SHC
  • Previous Close 18.70
  • Open 18.64
  • Bid 17.04 x 200
  • Ask 19.77 x 200
  • Day's Range 18.01 - 18.74
  • 52 Week Range 13.09 - 19.85
  • Volume 428,571
  • Avg. Volume 2,245,990
  • Market Cap (intraday) 5.142B
  • Beta (5Y Monthly) 1.86
  • PE Ratio (TTM) 31.61
  • EPS (TTM) 0.57
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 22.61
  • Zacks Rating Bearish

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

soterahealth.com

3,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SHC
2.15%
S&P 500 (^GSPC)
10.90%

1-Year Return

SHC
10.28%
S&P 500 (^GSPC)
11.27%

3-Year Return

SHC
42.90%
S&P 500 (^GSPC)
82.19%

5-Year Return

SHC
27.04%
S&P 500 (^GSPC)
64.84%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 321.38M
Earnings 53.64M
Profit Margin 16.69%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
10.0%
12.0%
14.0%
16.0%

Analyst Insights

View More

Analyst Price Targets

17.00
22.61 Average
18.02 Current
25.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/14/2026
Analyst JP Morgan
Rating Action Downgrade
Rating Underweight
Price Action Announces
Price Target 17

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.44%

  • Return on Assets (ttm)

    8.60%

  • Return on Equity (ttm)

    27.78%

  • Revenue (ttm)

    1.22B

  • Net Income Avi to Common (ttm)

    163.48M

  • Diluted EPS (ttm)

    0.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    356.95M

  • Total Debt/Equity (mrq)

    340.73%

  • Levered Free Cash Flow (ttm)

    153.97M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: